To Contents

National Drug Intelligence Center
National Drug Threat Assessment 2007
October 2006

D-Links

Figure 1. Reported Methamphetamine Laboratory Seizures, 2001-2006.

Chart illustrating total reported methamphetamine laboratory seizures from 2001 to 2006.

In 2001, there were 8,460 reported methamphetamine laboratory seizures, 9,267 in 2002, 10,212 in 2003, 10,015 in 2004, 5,846 in 2005, and 2,159 in 2006.

Source: National Clandestine Laboratory Seizure System (Run date--September 13, 2006).
Data for 2006 are incomplete.

Return to Figure 1.

Figure 2. Reported Methamphetamine Superlab Seizures, 2001-2006.

Chart illustrating total reported methamphetamine superlab seizures from 2001 to 2006.

In 2001, there were 244 reported methamphetamine superlab seizures, 143 in 2002, 130 in 2003, 55 in 2004, 35 in 2005, and 17 in 2006. Note: The data for 2006 are incomplete.

Source: National Clandestine Laboratory Seizure System (Run date--September 13, 2006).
Data for 2006 are incomplete.

Return to Figure 2.

Figure 3. Percentage of primary methamphetamine or amphetamine admissions, by route of administration, 1993-2004.

Chart illustrating the percentage of primary methamphetamine or amphetamine admissions, by route of administration, from 1993 to 2004.

In 1993, the smoking admissions percentage was 15.0, 17.10 in 1994, 18.9 in 1995, 22.1 in 1996, 27.4 in 1997, 32.0 in 1998, 35.1 in 1999, 39.8 in 2000, 45.1 in 2001, 50.7 in 2002, 56.2 in 2003, and 59.1 in 2004.

In 1993, the inhalation admissions percentage was 42.7, 43.3 in 1994, 43.0 in 1995, 39.0 in 1996, 36.3 in 1997, 31.0 in 1998, 25.2 in 1999, 21.0 in 2000, 18.6 in 2001, 17.1 in 2002, 15.1 in 2003, and 13.6 in 2004.

In 1993, the injection admissions percentage was 29.0, 29.0 in 1994, 28.7 in 1995, 29.7 in 1996, 28.4 in 1997, 29.1 in 1998, 29.2 in 1999, 28.1 in 2000, 26.4 in 2001, 23.3 in 2002, 21.6 in 2003, and 21.1 in 2004.

In 1993, the oral admissions percentage was 12.6, 10.0 in 1994, 8.8 in 1995, 8.5 in 1996, 7.3 in 1997, 7.1 in 1998, 9.8 in 1999, 10.3 in 2000, 8.7 in 2001, 7.4 in 2002, 5.7 in 2003, and 4.9 in 2004.

Source: Treatment Episode Data Set.

Return to Figure 3.

Figure 4. Primary methamphetamine admissions, 2000-2004.

Chart illustrating total primary methamphetamine admissions from 2000 to 2004.

In 2000, there were 67,568 primary methamphetamine admissions, 82,113 in 2001, 105,981 in 2002, 117,259 in 2003, and 129,079 in 2004.

Source: Treatment Episode Data Set

Return to Figure 4.

Figure 5. Estimated number of methamphetamine users dependent on or abusing illicit drugs or stimulants, 2002-2004.

Chart illustrating the estimated number of methamphetamine users dependent on or abusing illicit drugs or stimulants from 2002 to 2004.

In 2002, the estimated number of methamphetamine users was 433,000 for no dependence or abuse; 101,000 for other illicit drug dependence or abuse; and 63,000 for stimulant dependence or abuse.

In 2003, the estimated number of methamphetamine users was 357,000 for no dependence or abuse; 158,000 for other illicit drug dependence or abuse; and 92,000 for stimulant dependence or abuse.

In 2004, the estimated number of methamphetamine users was 237,000 for no dependence or abuse; 216,000 for other illicit drug dependence or abuse; and 130,000 for stimulant dependence or abuse.

Source: National Survey on Drug Use and Health.

Return to Figure 5.

Figure 6. Average percentage of THC in samples of seized marijuana, 1985-2005.

Chart illustrating the average percentage of THC in samples of seized marijuana from 1985 to 2005.

In 1985, the average percentage of THC in samples of seized marijuana was 3.48, 2.80 in 1986, 3.20 in 1987, 3.70 in 1988, 3.78 in 1989, 3.82 in 1990, 3.26 in 1991, 3.16 in 1992, 3.65 in 1993, 3.75 in 1994, 3.96 in 1995, 4.50 in 1996, 5.01 in 1997, 4.91 in 1998, 4.59 in 1999, 5.34 in 2000, 6.10 in 2001, 7.20 in 2002, 7.14 in 2003, 8.13 in 2004, and 8.14 in 2005.

Source: The University of Mississippi Potency Monitoring Project.

Return to Figure 6.

Figure 7. Total marijuana seized in Northern Border states, in kilograms, 2001-2005.

Chart illustrating total marijuana seized in Northern Border states, in kilograms, from 2001 to 2005.

In 2001, there were 11,546 kilograms of marijuana seized in Northern Border states, 13,584 kilograms in 2002, 21,583 kilograms in 2003, 31,442 kilograms in 2004, and 26,414 kilograms in 2005.

Source: Federal-Wide Drug Seizure System.

Return to Figure 7.

Figure 8. Commercial disbursements of commonly abused pharmaceuticals,* United States, 2000-Midyear 2005.

Chart illustrating commercial disbursements of commonly abused pharmaceuticals in the United States from 2000 to midyear 2005.

In 2000, there were 56,711,299 commercial disbursements of commonly abused pharmaceuticals in the United States; 89,707,996 in 2001; 95,850,725 in 2002; 111,436,795 in 2003; 118,431,530 in 2004; and 117,582,905 projected in 2005.

Source: Drug Enforcement Administration.
*Commonly abused pharmaceuticals include codeine, methylphenidate, oxycodone, hydromorphone, hydrocodone, meperidine, methadone, morphine, fentanyl, cocaine, d-methamphetamine, d-amphetamine, and dl-amphetamine.

Return to Figure 8.

Map 1. Nine regions.

Map illustrating nine OCDETF regions.

The Pacific OCDETF region includes Alaska, Hawaii, American Samoa, Northern Mariana Islands, Guam, Washington, Oregon, Idaho, Nevada, and Northern and Central California.
The West Central OCDETF region includes Montana, Wyoming, Utah, Colorado, North Dakota, South Dakota, Nebraska, Kansas, Iowa, Missouri, Arkansas, and Southern Illinois.
The Southwest OCDETF region includes Oklahoma, Texas, New Mexico, Arizona, and Southern California.
The Great Lakes OCDETF region includes Minnesota, Wisconsin, Northern Illinois, Michigan, Indiana, Ohio, and Kentucky.
The Southeast OCDETF region includes Louisiana, Mississippi, Tennessee, Alabama, Georgia, South Carolina, and North Carolina.
The New England OCDETF region includes Maine, New Hampshire, Vermont, Massachusetts, Connecticut, and Rhode Island.
The New York/New Jersey OCDETF region includes New York and New Jersey.
The Mid-Atlantic OCDETF region includes Pennsylvania, Maryland, Delaware, West Virginia, Virginia, and the District of Columbia.
The Florida/Caribbean OCDETF region includes Florida, Puerto Rico, and the U.S. Virgin Islands.

Return to Map 1.

Map 2. National Drug Threat Survey 2006 greatest drug threat as reported by state and local agencies.

Chart illustrating the National Drug Threat Survey 2006 greatest drug threat as reported by state and local agencies.

36.5% of agencies reported cocaine as the greatest drug threat.

8.5% of agencies reported heroin as the greatest drug threat.

38.8% of agencies reported methamphetamine as the greatest drug threat.

11% of agencies reported marijuana as the greatest drug threat.

3.9% of agencies reported pharmaceuticals as the greatest drug threat.

Return to Map 2.

Map 3. Greatest drug threat by region.

Map illustrating the greatest drug threats in each OCDETF region.

The greatest drug threats in the Pacific OCDETF region are methamphetamine at 92.2%, marijuana at 4.1%, cocaine at 2.7%, pharmaceuticals at 0.6%, and heroin at 0.0%.

The greatest drug threats in the West Central OCDETF region are methamphetamine at 76.8%, cocaine at 17.6%, marijuana at 3.5%, heroin at 1.4%, and pharmaceuticals at 0.3%.

The greatest drug threats in the Southwest OCDETF region are methamphetamine at 74.6%, cocaine at 16.2%, marijuana at 6.3%, heroin at 1.3%, and pharmaceuticals at 0.6%.

The greatest drug threats in the Great Lakes OCDETF region are cocaine at 39.4%, methamphetamine at 27.6%, marijuana at 17.1%, heroin at 8.6%, and pharmaceuticals at 6.5%.

The greatest drug threats in the New England OCDETF region are heroin at 37.6%, cocaine at 33.2%, marijuana at 15.5%, pharmaceuticals at 9.3%, and methamphetamine at 1.9%.

The greatest drug threats in the New York/New Jersey OCDETF region are cocaine at 47.0%, marijuana at 25.9%, heroin at 18.5%, pharmaceuticals at 4.9%, and methamphetamine at 1.6%.

The greatest drug threats in the Mid-Atlantic OCDETF region are cocaine at 54.7%, heroin at 19.9%, marijuana at 15.0%, pharmaceuticals at 4.2%, and methamphetamine at 3.9%.

The greatest drug threats in the Southeast OCDETF region are cocaine at 54.7%, methamphetamine at 36.3%, pharmaceuticals at 4.3%, marijuana at 3.0%, and heroin at 0.9%.

The greatest drug threats in the Florida/Caribbean OCDETF region are cocaine at 75.6%, methamphetamine at 12.7%, marijuana at 9.5%, pharmaceuticals at 0.4%, and heroin at 0.0%.

Return to Map 3.

Map 4. Areas of influence of drug trafficking organizations in the United States.

Maps illustrating the areas of influence of Mexican, Colombian, and Asian drug trafficking organizations in the United States.
The map shows the influence of Mexican drug trafficking organizations throughout the country with the exception of areas along the northern border.
The map shows the influence of Colombian drug trafficking organizations in parts of Colorado, Texas, Kansas, Missouri, Illinois, Georgia, Florida, and Puerto Rico and along the eastern coast from Delaware to New Hampshire.
The map shows the influence of Asian drug trafficking organizations in parts of California, Nevada, Arizona, Washington, Colorado, Kansas, Minnesota, Iowa, Wisconsin, Illinois, and along the Gulf and Atlantic coasts from Texas to Maine. 

Source: Drug Enforcement Administration; Organized Crime and Drug Enforcement Task Force.

Return to Map 4.

Map 5. Vectors in the Transit Zone--CCDB-documented cocaine flow departing South America, January-December 2005.

Map illustrating vectors in the transit zone of CCDB-documented cocaine flow departing South America from January to December 2005.

50% moves along the Eastern Pacific vector, 38% moves along the West Caribbean vector, 2% along the Jamaica vector, 4% along the Haiti/Dominican Republic vector, less than 1% direct to the continental U.S., less than 1% along the Puerto Rico/U.S. Virgin Islands vector, and 2% along the ABC/LA vector.

Percentages are based on all confirmed, substantiated, and higher-confidence suspect events in the Consolidated Counterdrug Database (CCDB).

Source: Interagency Assessment of Cocaine Movement, Midyear CY 2006 Update.

Return to Map 5.

End of page.